LONDON–(BUSINESS WIRE)– Commonwealth Bank of Australia Issue of USD 25,000,000.00 Collared Floating Rate Notes due 20 March 2034 Series 6579 Tranche 1 MTN ISSUE NAME. Our Ref. MQ8179 ISIN Code. XS2787874192 TOTAL INTEREST AMT. CURRENCY CODE. USD DAY BASIS. 30/360 BOND BASIS (A001) NUM OF DAYS. 90 INTEREST RATE. 4.71816 PCT VALUE DATE. 21/09/2026 INTEREST PERIOD. 20/06/2026 TO 20/09/2026 USD 294,885.000000 POOL FACTOR. N/A
Month: September 2026
DARMSTADT, Germany–(BUSINESS WIRE)–Adabas & Natural (A&N) today announced the appointment of Hans Roth as Chief Executive Officer, effective November 1. The appointment marks a defining moment as A&N enters its next chapter positioned for sustained, accelerating growth. Following the carveout of webMethods, StreamSets, Alfabet, Cumulocity, TrendMiner, and ARIS from Software GmbH, A&N is now back to its original roots as the multi-decade leading mission-critical database and in
LONDON–(BUSINESS WIRE)– Re: Atlas Funding 2024-1 PLC GBP 340,670,000.00 MATURING: 20-Sep-2061 ISIN: XS2819819942 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 4.59 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 835,053.76 PER GBP 207,680,090.58 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: Atlas Funding 2025-2 plc GBP 5,130,000.00 MATURING: 20-Jul-2067 ISIN: XS3212016870 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 5.39 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 25,500.06 PER GBP 5,399,997.12 DENOMINATION
LONDON–(BUSINESS WIRE)– Australia and New Zealand Banking Group Issue of EUR 750,000,000.00 Floating Rate Notes due March 2027 Series No 2188 Tranche No 1 ISSUE NAME. Our Ref. MV9448 ISIN Code. XS3304302063 INTEREST AMT PER DENOM. CURRENCY CODE. EUR DAY BASIS. Actual/360 (A004) NUM OF DAYS. 91 INTEREST RATE. 2.49563 PCT VALUE DATE. 21/09/2026 INTEREST PERIOD. 22/06/2026 TO 21/09/2026 EUR 1,000.00 IS EUR 6.31 POOL FACTOR. N/A
PARIS–(BUSINESS WIRE)– TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) and Mistral announce a 3-year joint program representing an investment of more than €100 million aimed at developing a new generation of frontier AI models to support TotalEnergies’ geosciences experts in the exploration, characterization and development of oil and gas reservoirs. Driving Innovation by Combining AI, Geoscience Expertise and Subsurface Data This partnership will draw on the latest advances in artificial int
LONDON–(BUSINESS WIRE)– Re: Darrowby No 6 PLC GBP 500,000,000.00 MATURING: 21-Sep-2071 ISIN: XS2893515150 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Jun-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 4.25 PCT DAY BASIS: ACTUAL/365(GBP) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 5,327,971.04 PER GBP 503,113,100.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: HOPS HILL NO 5 GBP 320,492,000.00 MATURING: 21-Jun-2056 ISIN: XS3102045369 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 4.47 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 1,259,161.11 PER GBP 331,958,678.99 DENOMINATION
PARIS–(BUSINESS WIRE)–Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris : ALIKO), groupe international des sciences de la vie dédié au diagnostic oncologique intégré, annonce le lancement du projet Probantes au Brésil, la constitution en cours de Probantes Ltda, une nouvelle unité commerciale brésilienne détenue à 100 % par Aliko Scientific Srl, ainsi que la signature d’un accord de coopération industrielle stratégique avec Biodetecta – Life Science Ltda. Francesco Trisol
PARIS–(BUSINESS WIRE)–Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces the launch of the Probantes project in Brazil, the ongoing incorporation of Probantes Ltda, a new Brazilian business unit wholly owned by Aliko Scientific Srl, and the signing of a strategic industrial cooperation agreement with Biodetecta – Life Science Ltda. Francesco Trisolini, CEO of Aliko Scienti